Cationic transfersomes based topical genetic vaccine against hepatitis B

International Journal of Pharmaceutics

Volumn 340, Issue 1-2, 2007, Pages 13-19

  Mahor, Sunil ^a   Rawat, Amit ^a   Dubey, Praveen K ^a   Gupta, Prem N ^a   Khatri, Kapil ^a   Goyal, Amit K ^a   Vyas, S P ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Cationic transfersomes; DNA vaccine; Hepatitis B; Non invasive immunization; Topical vaccine

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CATION; CATIONIC TRANSFEROSOME; DEOXYCHOLATE SODIUM; DNA VACCINE; DRUG CARRIER; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 2; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BAGG ALBINO MOUSE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; ANTIBODY FORMATION; CATIONS; DEOXYCHOLIC ACID; FEMALE; GENE TRANSFER TECHNIQUES; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS; RECOMBINANT PROTEINS; TIME FACTORS; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 34447285025     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.03.006     Document Type: Article

References (27)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Bergh B.A.I., Wertz P.W., Junginger H.E., and Bouwstra J.A. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int. J. Pharm. 217 (2001) 13-24
3. Cevc G., Blume G., Schatzlein A., and Gebauer D. The skin: a pathway for the systemic treatment with patches and lipid-based agent carriers. Adv. Drug. Deliv. Rev. 18 (1996) 349-378
4. Cevc G., Gebauer D., Stieber J., Schatzlein A., and Blume G. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368 (1998) 201-215
5. Cevc G., Schatzlein A., and Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release 36 (1995) 3-16
6. Constant S.L., and Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15 (1997) 297-322
7. Cruz P.D., and Bergstresser P.R. Antigen processing and presentation by epidermal langerhans cells, induction of immunity or unresponsiveness. Dermatol. Clin. 8 (1990) 633-647
8. Davis H.L. DNA-based vaccination against hepatitis B virus. Adv. Drug. Deliv. Rev. 21 (1996) 33-47
9. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J. Immunol. 175 (2005) 633-639
10. Fry D.W., White J.C., and Goldman I.D. Rapid separation of low molecular weight solute from liposomes without dilution. Anal. Biochem. 90 (1978) 809-815
11. Geissler M., Tokushige K., Chante C.C., Zurawski V.R., and Wands J.R. Cellular and humoral immune responses to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 112 (1997) 1307-1320
12. Gupta P.N., Mishra V., Rawat A., Dubey P., Mahor S., Jain S., Chatterji D.P., and Vyas S.P. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int. J. Pharm. 293 (2005) 73-82
13. Gupta P.N., Mishra V., Singh P., Rawat A., Dubey P., Mahor S., and Vyas S.P. Tetanus toxoid loaded transfersomes for topical immunization. J. Pharm. Pharmacol. 57 (2005) 1-7
14. Gupta P.N., Singh P., Mishra V., Jain S., Dubey P.K., and Vyas S.P. Topical immunization: mechanistic insight and novel delivery systems. Ind. J. Biotechnol. 3 (2004) 9-21
15. Hassett D.E., and Whitton J.L. DNA immunization. Trends Biotechnol. 4 (1996) 307-312
16. Hofer C., Hartung R., Gobel R., Deering P., Lehmer A., and Breul J. New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspects. World J. Surg. 24 (2000) 1187-1189
17. Leclere C., Deriaud E., Rojas M., and Whalen R.G. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell. Immunol. 79 (1997) 97-106
18. Lee E.H., Kim A., Oh Y.K., and Kook C. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26 (2005) 205-210
19. Mishra V., Mahor S., Rawat A., Dubey P., Gupta P.N., Singh P., and Vyas S.P. Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine 24 (2006) 5559-5570
20. Nakane A., Numata A., and Minagawa T. Endogenous tumour necrosis factor, interleukin-6 and gamma interferon levels during Listeria monocytogenes infection in mice. Infect. Immun. 60 (1992) 523-528
21. Perrie Y., and Gregoriadis G. Liposome-entrapped plasmid DNA: characterisation studies. Biochim. Biophys. Acta 1475 (2000) 125-132
22. Rich J.D., Ching C.G., Lally M.A., Gaitanis M.M., Schwartzapfel B., Charuvastra A., Beckwith C.G., and Flanigan T.P. A review of the case for hepatitis B vaccination of high-risk adults. Am. J. Med. 114 (2003) 316-318
23. Schuler G., and Steinman R.M. Murine epidermal langerhans cells mature into potent immunostimulatory dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 96 (1998) 13147-13152
24. Singh R.P., Singh P., Mishra V., Prabakaran D., and Vyas S.P. Vesicular systems for non-invasive topical immunization: rational and prospects. Ind. J. Pharmacol. 34 (2002) 301-310
25. Tuteja R. DNA vaccines: a ray of hope. Crit. Rev. Biochem. Mol. Biol. 34 (1999) 1-24
26. Udey M.C. Cadherins and langerhans cells immunobiology. Clin. Exp. Immunol. 107 (1997) 6-8
27. Vyas S.P., Singh R.P., Jain S., Mishra V., Mahor S., Singh P., Gupta P.N., Rawat A., and Dubey P. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int. J. Pharm. 296 (2005) 80-86